Product Information

OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.1719 per EA under NDC 10702018601. Its NADAC has been published 350 times since Sep 11, 2019.

FDA first approved this application on Feb 9, 2018. Its Orange Book therapeutic-equivalence code is AA.

The High Outlier badge above means this manufacturer's average price in the Oxycodone and Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET

Oxycodone and Acetaminophen
$0.1719per EA
High Outlier
DEA Schedule CII

Strength

325; 7.5 mg/1; mg/1

Manufacturer

KVK-Tech Inc.

NDC

10702018601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ACETAMINOPHEN; OXYCODONE

Approval Type

Generic (ANDA)

FDA Application

ANDA210644

FDA Approved

2/9/2018

TE Code

AA

On Market Since

2/9/2018

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 350 times since Sep 11, 2019, and over the history we have for it it has declined 14.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1719 per EA
All-time high$0.2438 (Apr 15, 2020)
All-time low$0.0972 (Jul 21, 2021)
52-week high$0.1842
52-week low$0.1719
Median price$0.1650
Average price$0.1649
Largest weekly change-39.0% (Apr 22, 2020)
Weeks tracked350
Tracking sinceSep 11, 2019

Price History

1W

-5.9%

1M

-5.8%

3M

-5.8%

6M

-2.0%

1Y

-5.6%

3Y

+7.1%

5Y

+73.8%

All

-14.3%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by KVK-Tech Inc., is $0.1719 per EA (NDC 10702018601), effective Nov 18, 2026.

How has the price of OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 14.3%. It has been tracked across 350 weekly CMS publications since Sep 11, 2019.

What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Since Sep 11, 2019, the NADAC for OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0972 (Jul 21, 2021) to a high of $0.2438 (Apr 15, 2020), with a median of $0.1650 per EA.

Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, is $0.1272 per EA — about 26% below OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET.

Who manufactures OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

OXYCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 10702018601) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.